- Report
- May 2022
- 40 Pages
China
From €2501EUR$2,595USD£2,151GBP
- Report
- May 2022
- 40 Pages
Brazil
From €2501EUR$2,595USD£2,151GBP
- Report
- February 2024
- 112 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- October 2023
- 92 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- October 2023
- 104 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- August 2023
- 96 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- May 2022
- 80 Pages
Africa
From €3657EUR$3,795USD£3,146GBP
- Book
- November 2008
- 312 Pages
The Human Vaccine market is a segment of the larger Vaccine industry, which focuses on the development and distribution of vaccines to protect humans from infectious diseases. Vaccines are typically administered through injections, although some may be administered orally or nasally. Vaccines are designed to stimulate the body's immune system to recognize and fight off a particular disease. Vaccines are typically developed through a combination of laboratory research, clinical trials, and regulatory approval.
The Human Vaccine market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market are focused on developing new vaccines, as well as improving existing vaccines. They are also involved in the production, distribution, and marketing of vaccines.
Some of the major companies in the Human Vaccine market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson, and Novartis. Show Less Read more